Directors and Officers

 Dr. Jianhua Yang , our founder, has served as the chairman of the board of directors and the chief executive officer of Chemspec since its inception in 2006. Dr. Yang has been chairman and chief executive officer of Shanghai ChemSpec since he founded it in 1996. Dr. Yang has more than 20 years of experience in fluorinated specialty chemicals. Dr. Yang graduated from the Shanghai Institute of Organic Chemistry of the Chinese Academy of Sciences with a Ph.D. in science in 1988. In 1991, Dr. Yang was awarded with the National Natural Science Award (First Class) by the Chinese Academy of Sciences and in 1993, was awarded with the National Natural Science Award (Second Class) by the State Commission on Science and Technology of China.

Dr. David Yunhung Tang was appointed as a member of our board of directors in July 2008. Dr. Tang has worked for Shanghai ChemSpec as executive vice president of marketing and research and development since 2001. Dr. Tang is responsible for overseeing our research and development and marketing activities. Dr. Tang has more than 30 years of experience in fluorinated specialty chemicals, having worked in a range of positions for Occidental Chemical Corporation, Buffalo, New York, from 1977 to 2000, including research scientist, technology group leader, technical manager, senior manager, general manager of a joint venture of Occidental Chemical Corporation and research fellow. In 1973, he obtained a Ph.D. from Indiana University, USA. In 1985, he obtained an MBA degree from the State University of New York at Buffalo, USA, and in 1987 he completed an executive management program at Northwestern University.

Mr. Bing Zhu was appointed our chief financial officer in June 2008 and our director in June 2009. From May 2006 until June 2008, he was chief financial officer of Canadian Solar Inc., a Nasdaq-listed solar cell and module products manufacturer based in China. From March 2005 until May 2006, he was financial controller and acting chief financial officer of Canadian Solar Inc. Prior to that, Mr. Zhu was a commercial banking relationship account manager at Royal Bank of Canada. From May 1996 to June 2000, Mr. Zhu worked as the Shanghai chief representative of Raytheon Corporation and was in charge of market development for its commercial electronics, engineering & construction and commercial aircraft divisions in China. From 1993 to 1996, he was a corporate banking account manager for Banque Indosuez. His customers included the China operations of European- and North American- based multi-national companies as well as B- and H- share Chinese public companies. From 1986 to 1992, Mr. Zhu was an accountant and then a finance manager in a Chinese state-owned enterprise in Hangzhou, China. Mr. Zhu received his bachelor’s degree in business management in 1986 from Zhejiang University of Technology in China, and his MBA degree in 1993 from China Europe International Business School (previously known as China-Europe Management Institute).

Dr. George Sun was appointed as a member of our board of directors in July 2008. Dr. Sun currently serves as general manager of Omaha Capital China, a China-focused early growth and venture capital fund focusing on life sciences, clean technology and high technology. Previously, he spent more than 10 years at McKinsey & Company as a senior management consultant where he assisted major companies in China in various industries on issues of strategy, organization and operations. Dr. Sun co-founded and served as the president of GanTech International Inc., a biopharmaceutical company. He also worked as a scientist at Rohm and Haas, a leading specialty chemicals company. Dr. Sun holds a Ph.D. in chemistry from California Institute of Technology, a M.S. in organic chemistry from Shanghai Institute of Organic Chemistry, and a B.S. in chemistry from University of Science and Technology of China. He also attended the advanced management program at the Wharton School, University of Pennsylvania.

Ted T. Lee became our independent director and chairman of our audit committee in June 2009. Mr. Lee is managing director of T Plus Capital Ltd., a firm he founded that provides strategic, financial and business development advisory services to accounting, financial valuation services and human capital firms in China. Since September 2008, he has served as senior advisor to Duff & Phelps, a global financial valuation firm, and, from September 2007 until April 2009, served as executive director at Prax Capital, a private equity firm specializing in China-focused investments. Prior to his current professional activities, Mr. Lee was a senior partner at Deloitte Touche Tohmatsu, or Deloitte, where he worked for 31 years in the United States and Asia, including heading the opening of Deloitte’s first China office in Shanghai in 1992, serving as office managing partner of their Hong Kong, Guangzhou and Beijing offices, and practicing in the firm’s Los Angeles and Taipei offices. Mr. Lee is a U.S. certified public accountant and holds an MBA in finance and accounting from the University of Southern California and a B.S. in accounting from California State University, Fresno.

Mr. Wujun Yang became vice president of Chemspec in July 2008 and is responsible for overseeing the construction of facilities and purchase of raw materials. Mr. Yang has worked for Shanghai ChemSpec since 1997. Mr. Yang has more than 30 years of experience in the manufacturing of chemicals. Mr. Yang graduated from the Shanghai Institute of Chemistry and Technology, majoring in chemical engineering in 1977. Prior to joining our company, he served as an engineer with the Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences from 1986 to 1996.

Mr. Xiaosong Yang has been vice president of marketing of Chemspec since July 2008 and is responsible for overseeing our marketing activities and has helped develop our business with pharmaceutical customers. He joined Shanghai ChemSpec in May 2006. Mr. Yang has more than 10 years of experience in pharmaceutical operations. Mr. Yang received a bachelor of medicine in forensic medicine in 1996 from the Shanghai Medical University in China, and a master of science in information systems in 2003 from Northeastern University in the U.S. He is pursuing an EMBA degree from China Europe International Business School. Between 2003 and 2006, Mr. Yang was a general manager of the Business Department at Summit Pharmaceuticals (China) Ltd., responsible for new drug development projects and new business development for both the European and the US markets. Between 2002 and 2003, he was an independent contractor with CoreStreet, Ltd. Between 1996 and 2000, he worked in business development and sales at Sumitomo Corporation (Shanghai) Ltd.

Mr. Zixin Wang has been vice president of Chemspec since July 2008 and is responsible for administration and human resources. From 2006 to 2007, he was the financial controller of Shanghai ChemSpec. Prior to joining us, he served as a project manager of Shanghai Boning Finance Advisory Limited, where he was responsible for advising on offshore initial public offerings of Chinese companies and investment activities in China of foreign companies. In 2004, he obtained his master’s degree in accounting from Shanghai Jiaotong University.

Mr. Yunlong Yuan has been vice president of Chemspec since July 2008 and is responsible for overseeing our manufacturing processes and operations. From 1998 to 2007, he was a director of research and development for Shanghai ChemSpec and was responsible for overseeing the research and development activities of Shanghai ChemSpec jointly with Dr. Tang. Mr. Yuan has more than 10 years of experience in fluorinated specialty chemicals. Mr. Yuan graduated from the chemistry department of East China University of Science and Technology majoring in industrial catalysis in 1996. Prior to joining our company, he served as a technician with Nanjing Chemical Industrial (Group) Co., Ltd.